Lakefront Biotherapeutics (LKFT) Free Cash Flow Growth (1y) (2015 - 2026)
Lakefront Biotherapeutics (LKFT) Free Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | 7.12% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn | 1,092.51% |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn | 66.37% |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn | 3.98% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 137.65% |
| 10 | Lakefront Biotherapeutics | 1.86 Bn | -1.54 Bn | 1.91 Mn | -149.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -149.36% |
| Dec 31, 2025 | 18.56% |
| Sep 30, 2025 | -32.75% |
| Jun 30, 2025 | 25.15% |
| Mar 31, 2025 | 71.07% |
| Dec 31, 2024 | 4.07% |
| Mar 31, 2024 | -41.08% |
| Dec 31, 2023 | 42.48% |
| Mar 31, 2023 | -75.85% |
| Jun 30, 2020 | -96.69% |
| Mar 31, 2020 | 4.92% |
| Dec 31, 2019 | -145.43% |
| Sep 30, 2019 | 103,233.02% |
| Jun 30, 2019 | -7.41% |
| Mar 31, 2019 | -41.23% |
| Dec 31, 2018 | -124.61% |
| Sep 30, 2018 | -100.01% |
| Jun 30, 2018 | 99.90% |
| Mar 31, 2018 | -77.47% |
| Jun 30, 2017 | -256,384.73% |